Quantcast
Home / News / A drug by any other name? Supreme Court considers if generic drug suits are preempted (access required)

A drug by any other name? Supreme Court considers if generic drug suits are preempted (access required)

By KIMBERLY ATKINS, Lawyers USA, the national sister paper of Lawyers Weekly kimberly.atkins@lawyersusaonline.com   Two years after the U.S. Supreme Court ruled in Wyeth v. Levine that state law failure-to-warn claims against brand-name drug makers are not automatically preempted by federal law, the justices are considering whether that same rule applies to generic drug makers. The plaintiffs in ...

Leave a Reply

Your email address will not be published. Required fields are marked *

*